Has Ann Beck received payments from drug or device companies?

Yes. Drug and device makers reported $6,785 in general payments to Ann Beck across 335 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ann Beck did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ann Beck come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ann Beck

Family · Charleston, WVNPI 1831743616

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,490 of the $6,785 with a category attached, or 80.9%. 22 manufacturers reported payments, led by Medtronic at 26.5% of the total. Reporting peaked in 2022 at $3,538 and has fallen 95.4% since, to $164 in 2025. Among family clinicians in WV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,785in general payments, 2019–2025

Across 335 payments — averaging $20.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$2K
Johnson & Johnson$945
Boehringer Ingelheim$659
Novartis$491
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$484
Merck$406
plus $2K from 16 others

What the payments were for

Travel & lodging$1,29519%
Food & beverage$5,49081%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic	22	$1,795
Johnson & Johnson	76	$945
Boehringer Ingelheim	30	$659
Novartis	30	$491
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	29	$484
Merck	24	$406
Amgen	18	$354
AstraZeneca	17	$315
Amarin Pharma, Inc.	17	$245
Esperion Therapeutics, Inc.	17	$243
Pfizer	15	$232
GSK	10	$214
E.r. Squibb & Sons, L.L.C.	17	$162
Alnylam Pharmaceuticals Inc.	3	$54
Sanofi Pasteur Inc.	2	$45
Cvrx, Inc.	2	$31
Collegium Pharmaceutical, Inc.	1	$25
Ironshore Pharmaceuticals Inc.	1	$22
Regeneron Healthcare Solutions, Inc.	1	$20
Neos Therapeutics, LP	1	$17
Bayer	1	$14
Amryt Pharma Holdings Ltd	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,785 in reported general payments places this provider in the 95th percentile of 1,507 family providers in West Virginia.

See all family providers in West Virginia →

Other family in Charleston

Ashley ComerCharleston$213K
Sarah KnightCharleston$99K
Angela SettleCharleston$51K
Malea SmithCharleston$13K
Michelle MurrayCharleston$13K
Kara DravenstottCharleston$11K
Stacy RichardsonCharleston$11K
Rebecca ButcherCharleston$9K
Jade LewisCharleston$8K
Ashton HolbrookCharleston$8K

See the full list for West Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →